Gaxos.ai (NASDAQ: GXAI) has outlined its operating strategy following the sale of its gaming assets, signaling a sharpened focus on expanding its AI applications business through Gaxos Labs and the personalized health and wellness offerings of its majority-owned subsidiary RNK Health. The company said the strategic realignment follows significant first-quarter 2026 revenue growth to approximately $1.81 million, driven primarily by RNK Health and subscriptions to Gaxos Labs applications.
According to the company’s announcement, Gaxos.ai’s priorities include scaling revenue-generating platforms, improving customer acquisition efficiency, advancing commercially focused AI products, and maintaining disciplined capital allocation. The company also said it will continue to hold its 19.99% ownership interest in America First Defense.AI while providing separate reporting on that investment. Additionally, it plans to enhance investor communications with additional operating performance metrics as its businesses continue to grow.
Gaxos.ai is a technology company focused on reshaping how people interact with artificial intelligence across everyday life and high-impact industries. The company is building a portfolio of AI-powered solutions designed to make advanced technology more practical, accessible, and transformative. Its growing portfolio spans defense, health and wellness, entertainment, and productivity—bringing intelligent tools to markets where innovation can drive meaningful real-world outcomes.
For more information, the full press release is available at https://ibn.fm/G9Ld7. The latest news and updates relating to GXAI are available in the company’s newsroom at https://ibn.fm/GXAI.
